Merck & Co Inc (MRK)

pos +0.00
Today's Range: 61.03 - 61.90 | MRK Avg Daily Volume: 10,298,100
Last Update: 10/21/16 - 4:00 PM EDT
Volume: 0
YTD Performance: 15.87%
Open: $0.00
Previous Close: $61.92
52 Week Range: $47.97 - $64.86
Oustanding Shares: 2,765,208,203
Market Cap: 171,221,691,930
6-Month Chart
TheStreet Ratings Grade for MRK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 6 6 4
Moderate Buy 0 0 0 0
Hold 6 7 7 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.86 2.08 2.08 2.33
Latest Dividend: 0.46
Latest Dividend Yield: 2.97%
Dividend Ex-Date: 09/13/16
Price Earnings Ratio: 34.02
Price Earnings Comparisons:
MRK Sector Avg. S&P 500
34.02 34.20 29.40
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
4.10% 20.97% 31.58%
Revenue -6.50 -0.20 -0.06
Net Income -62.60 -0.30 -0.11
EPS -61.70 -0.20 -0.08
Earnings for MRK:
Revenue 39.50B
Average Earnings Estimates
Qtr (09/16) Qtr (12/16) FY (12/16) FY (12/17)
Average Estimate $0.98 $0.94 $3.74 $3.88
Number of Analysts 9 6 11 11
High Estimate $1.01 $0.98 $3.76 $4.16
Low Estimate $0.97 $0.87 $3.71 $3.67
Prior Year $0.96 $0.93 $3.59 $3.74
Growth Rate (Year over Year) 2.55% 1.08% 4.15% 3.72%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Look for solid companies showing life.
Oct 13, 2016 | 7:17 AM EDT
MRK was upgraded from Neutral to Buy, Bank of America/Merrill Lynch said. $70 price target. Estimates also increased, as the company sh...
The stock's healthy recent pattern appears to be giving way to a fresh bull leg.
Drug trial results dominate the market's biggest movers, while Twilio announces a secondary offering.
Zoetis is not averse to a little noise as investors, analysts take notice.

Intermediate Trade: Merck Real Money Pro($)

The tactic is a slightly out-of-the-money, bearishly biased vertical put spread expiring in November.
The market continues to defy those players who believe we are seeing the calm before the storm.
Besides Tesla, Twitter and Biogen make good candidates.
There's a price to pay for low expectations.
BMY is unlikely to stay in the low $60s for long.


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.